Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
434.50    -0.50 (-0.11%)
Bid:
432.50
Ask:
435.00
Spread: 2.50 (0.578%)
Market Cap: £213.70m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Update

9 Jul 2012 07:00

RNS Number : 1636H
Zotefoams PLC
09 July 2012
 



 

9 July 2012

 

Zotefoams plc

("Zotefoams" or "the Company")

 

Trading Update

 

9 July 2012 - Zotefoams, which manufactures and sells high-performance foams, today announces its trading update for the six months ended 30 June 2012.

 

Zotefoams has experienced good revenue growth in the first half of 2012 with an increase in reported sales of approximately 10% on the same period last year.

 

In constant currency our Azote® polyolefin foam business grew in all major markets with substantial growth in Asia and a particularly pleasing performance in both the UK and North America. Sales in our High-Performance Polymer foams business are significantly ahead of the same period last year, driven by growth in aviation applications from North America. The average price paid for low density polyethylene ("LDPE"), our major raw material, was lower than the same period in 2011. However, the benefit of this and the sales growth was somewhat mitigated by the negative impact of a weaker euro and higher energy costs.

 

The development pipeline of new projects at MuCell Extrusion LLC ("MEL") is growing well from a small base, although revenue from existing licensees is anticipated to be below the same period last year. We expect good progress in conversion of additional signed MEL licences over the coming years as a consequence of the investments we are making in this business.

 

Overall, the Company is trading in line with the Board's expectations for the full year with a strong order book and, while we are mindful of the potential impact of economic conditions and movements in currency rates, we continue to expect 2012 to be yet another year of progress and remain confident about the long-term prospects of the business.

 

The Company will announce its interim results for the six months ended 30 June 2012 on Tuesday, 7 August 2012.

 

 

Enquiries:

Zotefoams plc

0208-664-1600

David Stirling, Managing Director

Clifford Hurst, Finance Director

FTI Consulting

0207-831-3113

Ben Brewerton, John Dineen

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular material technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces lightweight foams in Croydon, UK and Kentucky, USA for diverse markets worldwide through its global sales force. Zotefoams also owns and licenses patented MuCell® microcellular foam technology from a base in Massachusetts, USA to customers worldwide and sells T-Tubes® advanced insulation systems made from its patented ZOTEK® fluoropolymer foams.

 

www.zotefoams.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDMGGNVVMGZZM
Date   Source Headline
4th Jun 20193:44 pmRNSHolding(s) in Company
4th Jun 20193:06 pmRNSDirector/PDMR Shareholding
28th May 201911:54 amRNSHolding(s) in Company
28th May 20199:38 amRNSHolding(s) in Company
21st May 20195:36 pmRNSDirector/PDMR Shareholding
21st May 201912:20 pmRNSHolding(s) in Company
20th May 20197:00 amRNSHolding(s) in Company
16th May 201912:46 pmRNSDirector/PDMR Shareholding
15th May 20193:51 pmRNSResult of AGM
15th May 20197:00 amRNSTrading Update
7th May 20199:11 amRNSDirector Declaration
25th Apr 20194:40 pmRNSDirector/PDMR Shareholding
17th Apr 20192:35 pmRNS2018 Annual Report and Notice of the 2019 AGM
16th Apr 20194:41 pmRNSDirector/PDMR Shareholding
12th Apr 20193:54 pmRNSDirector/PDMR Shareholding
4th Apr 201911:01 amRNSHolding(s) in Company
29th Mar 201912:57 pmRNSHolding(s) in Company
22nd Mar 20192:21 pmRNSHolding(s) in Company
19th Mar 20197:00 amRNSFinal Results
18th Mar 20194:12 pmRNSHolding(s) in Company
14th Mar 201911:46 amRNSDirector/PDMR Shareholding
5th Mar 20195:55 pmRNSDirector Declaration
14th Feb 20195:02 pmRNSDirector/PDMR Shareholding
28th Jan 20195:09 pmRNSHolding(s) in Company
28th Jan 20197:00 amRNSNotice of Results
15th Jan 20195:08 pmRNSDirector/PDMR Shareholding
15th Jan 20192:06 pmRNSHolding(s) in Company
9th Jan 20193:48 pmRNSHolding(s) in Company
7th Jan 201911:41 amRNSHolding(s) in Company
7th Jan 201911:37 amRNSHolding(s) in Company
7th Jan 201910:37 amRNSHolding(s) in Company
7th Jan 201910:33 amRNSHolding(s) in Company
19th Dec 20189:11 amRNSHolding(s) in Company
13th Dec 20181:16 pmRNSDirector/PDMR Shareholding
10th Dec 20187:00 amRNSHolding(s) in Company
27th Nov 20185:26 pmRNSHolding(s) in Company
19th Nov 20185:37 pmRNSHolding(s) in Company
13th Nov 201812:36 pmRNSDirector/PDMR Shareholding
8th Nov 20187:30 amRNSHolding(s) in Company
7th Nov 201812:50 pmRNSHolding(s) in Company
1st Nov 20187:00 amRNSTrading Update
12th Oct 20185:06 pmRNSDirector/PDMR Shareholding
12th Sep 20184:14 pmRNSDirector/PDMR Shareholding
22nd Aug 20184:34 pmRNSHolding(s) in Company
22nd Aug 20182:05 pmRNSHolding(s) in Company
15th Aug 201811:59 amRNSHolding(s) in Company
15th Aug 201811:53 amRNSDirector/PDMR Shareholding
7th Aug 20187:00 amRNSInterim Results
25th Jul 20182:47 pmRNSHolding(s) in Company
25th Jul 20182:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.